# Protalix BioTherapeutics, Inc.: Form 8-K, filed Jun 26, 2025

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2025-06-26
- Accepted by EDGAR: Jun 26, 2025, 20:30 ET
- Period: 2025-06-26
- Accession: 0001558370-25-008922
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837025008922/plx-20250626x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837025008922/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837025008922/plx-20250626x8k.htm

Filed Jun 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-008922. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.